Skip to main content
PLOS One logoLink to PLOS One
. 2024 Jul 25;19(7):e0305627. doi: 10.1371/journal.pone.0305627

Longitudinal evidence over 2 years of the pandemic shows that poor mental health in people living with obesity may be underestimated

Matthew J Vowels 1, Laura M Vowels 2, Jilly Gibson-Miller 3,*
Editor: Jordi Gumà4
PMCID: PMC11271889  PMID: 39052556

Abstract

It is well-documented that people living with obesity are at greater risk of poorer mental health outcomes. The aim of our study was twofold: First, to examine the longitudinal trajectories of depression and anxiety in people living with obesity over two years across eight waves of a UK national COVID-19 survey (March 2020-March 2022) using smoothing-splines mixed-effects models. Second, to investigate participation effects via a missingness analysis to check whether survey attrition over time was related to participant characteristics. Trajectory models showed that those living with overweight and obesity consistently reported significantly higher rates of anxiety and depression compared to those in normal weight categories over two years. Our missingness analysis revealed that depression and anxiety predicted the likelihood of responding to the survey over time, whereby those reporting higher rates of depression and anxiety were less likely to respond to the survey. Our findings add to the literature surrounding the (long-term) link between living with obesity and poor mental health. Notably, our results suggest that people who have poorer mental health were less likely to participate in the survey. Thus, we conclude that it is likely that longitudinal population survey studies potentially underreport mental health problems over time and therefore the realistic impact of obesity on mental health outcomes may be underestimated.

Introduction

The unprecedented circumstances surrounding the COVID-19 pandemic have disproportionately affected populations at high risk of serious outcomes, including those living with obesity (BMI ≥ 30 kg/m^2) who had higher odds of intensive care unit admissions, being placed on a mechanical ventilator, and death [1, 2]. As a consequence, individuals who were identified as obese in the United Kingdom were asked to ‘shield’ (i.e., completely avoid contact with other people) for 1.5 years between March 2020 and September 2021. Although there were variations in population mental health, research has shown that mental health problems in particular groups of people, such as those with chronic health conditions, increased significantly during the pandemic [3]. In particular, self-isolation or shielding was especially detrimental to people’s well-being [4, 5]. Pre-pandemic studies indicate a higher prevalence of mental health issues among individuals with obesity, whereby there is a bidirectional relationship between obesity and poor mental health (i.e., the likelihood of mental health problems increases for those with higher body weight) [6, 7]. For example, a study of 363 037 patients showed that higher body mass index (BMI) was associated with a higher likelihood of depression [7]. Likewise, a meta-review [8] found a statistically significant association between obesity and depression with those who had a BMI above 40, associated with greater odds of becoming depressed. One recent study has estimated the prevalence of depressive and anxiety disorders in obese patients at 29.23% and 25.56%, respectively [9].

The pandemic, intensifying this pre-existing vulnerability, has likely disproportionately amplified mental health problems for these individuals due to imposed self-isolation measures and general health risks associated with obesity [3]. Recent work [1] clearly illustrates that obesity is a risk factor for poorer mental health outcomes during the pandemic, including higher levels of depression and lower well-being, and more anxiety, fear, and worry about the pandemic, compared to pre-pandemic experiences [1012].

In the present study, we examined the mental health (depression and anxiety) trajectories of people living with obesity compared to those who identified as overweight or normal weight across two years (eight points of data collection) of the COVID-19 pandemic (March 2020 –March 2022). We used survey data from a large nationally representative sample collected in the United Kingdom. Based on previous research, we expected that individuals living with obesity would report worse mental health outcomes during the pandemic followed by participants who reported being overweight with participants in the normal weight category reporting the lowest levels of depression and anxiety.

In addition to examining the mental health trajectories of people in different weight categories over the two-year period, we also aimed to understand how sample recruitment and the associated drop-out/top-up may affect the results within the study as well as potentially within other longitudinal survey studies examining obesity and mental health. When collecting longitudinal data, one must contend with participant drop-out/non-response, and/or top-up as a recruitment measure which helps compensate for drop-out by introducing additional participants to the study. Unfortunately, there is a risk that drop-out and top-up are non-random; sometimes drop-out occurs at times of difficulty for the participant, and these difficulties may be associated with the measures of interest for the study (in our case, the reasons for drop-out may be related to the participants’ levels of depression or anxiety, or obesity itself). Similarly, top-up can also result in skew, because even if the original participant invitations are representative, the participants who finally agree to participate may not be. Furthermore, even if the new participants are representative, their inclusion may not complement the skew of the participants who dropped-out and may even exacerbate the imbalance that resulted from the non-random drop-out. As such, and to investigate whether drop-out or top-up could have resulted in a skew in the average levels of depression and anxiety at each timepoint, we attempted to predict how each participant who responded at least once throughout the study was likely to have responded at each of the timepoints separately.

Materials and methods

Participants and procedure

We conducted a secondary analysis of the longitudinal, COVID-19 Psychological Research Consortium Study (C19PRCS) data. A detailed methodological account is available elsewhere [1315] but below we provide a brief description of the study methodology.

The data were collected through an internet-based survey fielded by UK survey company, Qualtrics. The survey included measures of socio-demographic characteristics, health characteristics and behaviour, knowledge, attitudes and beliefs in relation to COVID-19, mental health indicators, social attitudes, and psychological variables. Quota sampling was used to recruit a panel of adults who were nationally representative of the UK population in terms of age, sex, and household income. Participants were aged 18 years or older at the time of the survey, must have been able to complete the survey in English, and be resident in the UK. Adults provided informed consent before completing the survey online and were reimbursed by Qualtrics for their time. Ethical approval for this research was provided by a UK University Psychology department (Reference number: 033759). In the present study, we used data from Waves 1–8 spanning the first two years of the COVID-19 pandemic (March 2020 –March 2022) from all participants who self-reported being normal weight, overweight, or obese (underweight participants were not included in the study) in at least one of the waves in which measures of weight category were available (Waves 3, 5, and 8). The summary characteristics are reported in Table 1. On average, 8.6% of our sample reported being obese, 44.6% overweight and 46.8% normal weight (for context, current UK data [16] indicate that population estimates are 35.9% Obese and 37.9% overweight).

Table 1. Participant summary characteristics at each timepoint.

Months Group Women Men Age Dep. GAD
Mean (SD) Min Max M(SD) M(SD)
0 Obese 63 51 47.40(14.13) 22 77 6.32(6.24) 6.18(5.92)
0 Overweight 325 322 51.69(14.68) 20 83 4.88(5.67) 4.77(5.33)
0 Normal weight 341 377 46.30(15.14) 18 83 4.23(5.56) 4.25(5.37)
1 Obese 44 45 50.29(13.90) 23 77 7.40(6.56) 5.76(5.71)
1 Overweight 257 271 53.57(13.97) 20 83 4.83(5.30) 3.95(4.86)
1 Normal weight 252 299 48.00(14.60) 18 83 4.20(5.44) 3.66(5.10)
4 Obese 88 68 45.29(14.78) 18 90 8.40(7.12) 7.03(6.48)
4 Overweight 392 398 49.06(15.68) 18 83 6.48(6.62) 5.09(5.70)
4 Normal weight 505 493 42.64(15.44) 18 89 5.39(6.08) 4.34(5.22)
8 Obese 124 85 48.94(13.66) 20 90 8.81(7.39) 6.97(6.49)
8 Overweight 529 526 52.98(14.55) 18 89 6.03(6.64) 4.71(5.68)
8 Normal weight 643 667 48.16(15.70) 18 92 4.77(6.02) 3.72(5.10)
12 Obese 111 79 49.34(13.66) 22 90 8.26(7.35) 6.78(6.54)
12 Overweight 513 512 53.25(14.48) 20 89 5.79(6.25) 4.56(5.52)
12 Normal weight 586 644 49.14(15.45) 18 92 4.58(5.78) 3.65(5.10)
17 Obese 69 52 45.66(14.06) 18 77 8.18(6.63) 6.32(6.04)
17 Overweight 355 352 50.62(14.83) 20 83 5.52(6.14) 4.35(5.35)
17 Normal weight 441 411 45.10(14.88) 18 89 4.24(5.73) 3.50(5.04)
20 Obese 50 39 46.53(13.39) 23 74 7.26(6.58) 5.53(5.96)
20 Overweight 265 285 51.08(14.89) 20 82 5.58(6.45) 4.46(5.65)
20 Normal weight 326 327 46.19(14.78) 18 89 4.00(5.43) 3.43(4.85)
24 Obese 90 79 42.17(14.49) 18 75 11.13(7.21) 8.35(6.22)
24 Overweight 448 390 47.53(15.46) 18 83 7.03(6.50) 5.35(5.66)
24 Normal weight 543 522 42.32(15.43) 18 89 5.77(6.31) 4.66(5.45)

Measures

Participants were asked to self-identify into one of four weight categories: underweight (4, removed from the analyses given the focus on obesity), normal (3), overweight (2), or obese (1). Depressive symptoms were measured using the Patient Health Questionnaire PHQ-9 [17], a 9-item self-report measure that asks participants the degree to which they have been bothered by depressive symptoms in the last two weeks (ranging from 0 [not bothered at all] to 2 [bothered a lot]). Higher scores indicative of higher levels of depression and scores of between 8–11 indicate diagnostic levels of depression that may require psychological intervention [18].

Anxiety was measured using the Generalized Anxiety Disorder 7-item Scale (GAD-7; [19]). Participants indicated how often they had been bothered by each symptom over the past 2 weeks on a four-point Likert scale (0 = Not at all, to 3 = Nearly every day). Again, higher scores are indicative of higher levels of anxiety. The means and standard deviations for both scales for each weight category can be found in Table 1.

Data analysis

Multilevel spline trajectories

First, we modelled the longitudinal trajectories of depressive symptoms and anxiety separately, and for each weight category group (obese, overweight, and normal weight). To model the longitudinal trajectories, we used smoothing-splines mixed-effects models, as provided in the R package sme [20]. The non-linear and mixed-effects components of the modelling technique allowed us to account for the auto-correlation present in repeated measures data, and to model the non-linear nature of each participant’s anxiety and depression trajectories. We were thus able to model the trajectory of each participant separately (at the participant level) and to then create a group level average trajectory with confidence intervals determined by the inter-individual variability. While the interpretation of such models can be quite involved (the smoothing splines entail a substantial parameterization), with these models we were nonetheless able to visually represent the average trajectories for each group and to understand whether these groups differed significantly from one another over time. The two hyperparameters for the model λμ and λυ control the degree of non-linearity / the flexibility of the splines at the average and the individual levels, respectively. The values are non-negative real values between 0 and positive infinity, and higher values impose more constraints on the flexibility of the splines. For our analysis λμ = λυ = 1.

Response / participation analysis

Second, we investigated the potential drop-out and top-up participation effects, both of which have the potential to result in skewed or biased results. Fig 1 shows whether or not a participant responded at a particular time point (black) or not (white). Furthermore, Table 2 provides some quantification of how many participants responded in at least X timepoints (left) and how many participants responded at each timepoint (right). To make the predictions, we aggregated all people who participated at least once in the longitudinal study (N = 4,143). In an ideal world, this aggregate sample would be close in its characteristics to the sample characteristics of participants at any single timepoint, and one would not be able to discern whether any individual participant in this aggregate was more or less likely to participate at any particular timepoint. This is because in an ideal world, top-up and drop-out would occur at random, and there would be nothing to differentiate the participation of each participant according to their characteristics. For each participant in this aggregate sample, we assigned a binary label for whether that participant responded (assign a 1) at each of the eight timepoints or not (assign a 0). We then attempted to correctly classify each participant’s response for each timepoint using their age, gender, weight category (obese, overweight, or underweight), and average depression and average anxiety levels (averaged over the available measurements for these variables).

Fig 1. Participant participation (black) or absence (white) sorted by degree of participation over time (high participation at the top, low participation at the bottom).

Fig 1

Table 2. How many participants completed at least X number of timepoints (two leftmost columns), and how many participants there were at each timepoint (two rightmost columns).
No. of Timepoints No. with at least X Timepoints of Participation Month No. of Participants (% of total participants)
1 4143 0 1479 (36.7%)
2 3097 1 1168 (28.2%)
3 2150 4 1944 (46.9%)
4 1756 8 2574 (62.1%)
5 1452 12 2445 (59.0%)
6 1082 17 1600 (38.6%)
7 657 20 1292 (31.2%)
8 317 24 2072 (50.0%)

We used machine learning techniques to investigate the degree to which participants’ characteristics were related to their participation to explore whether the trajectories themselves might be determined by these effects (in our case, the reasons for drop-out or top-up participation may be related to the participants’ levels of depression or anxiety). To investigate these effects, we used a gradient boosted decision tree [21]—specifically, one known as XGBoost classifier [22]—as implemented in the Scikit-Learn package in Python [23], to predict the missingness label for each participant in the aggregate sample, for each timepoint. We used a 66/33 train/test split to predict whether each participant who responded at least once throughout the study was likely to have responded at each of the timepoints separately. This train-test splitting helped us to cross-validate the trained model on unseen data. We then recorded the Balanced Accuracy performance of the XGBoost on these test data. Balanced Accuracy accounts for any imbalance in the dataset. Otherwise, predicting the majority category if the class imbalance is 90%/10% would result in an (unbalanced) accuracy of 90%, even though we would be misclassifying all the minority class examples. In contrast, in this example the Balanced accuracy would be 50%, which reflects the fact that we are not adequately discerning between the classes once we adjust for their relative prevalence in the data.

We used participants’ age, gender, their weight category, and average depression and average anxiety levels (averaged over the available measurements for these variables) as predictors. Finally, to understand which of age, gender, weight category, depression, or GAD are useful in making these predictions (and thereby understand whether the drop-out or top-up is causing bias in the dataset), we used the “SHapley Additive exPlanations” package (SHAP) [24, 25]. The SHAP method derives from Lloyd Shapley’s seminal work in the domain of game theory [26] and conceives of predictors as players in a collaborative game, where the goal is to maximise the predictive power of the algorithm. By exhaustively evaluating the impact that each individual predictor has in all possible combinations of predictors, the method can provide an estimation for the overall contribution of each predictor separately. It also provides us with a visualisation of how the distribution of predictor values pushes the model in one direction or the other. For example, high values of depression may push the model towards classification of the positive class, and vice versa for low values.

Results

Longitudinal trajectories of depression and anxiety

The longitudinal trajectories for depression and anxiety are shown in Fig 2. The results show that both anxiety and depression are significantly higher for people within the obese weight category (shown in red) than those in the overweight (shown in blue) or normal weight (green) categories. In general, people in the overweight category also had significantly higher levels of anxiety and depression than people of normal weight. For comparison, we have also provided the trajectories plotting the raw mean scores in S1 File (available on the OSF platform at https://osf.io/9t6ey/).

Fig 2.

Fig 2

Smoothed-Spline Mixed-Model Average Trajectories with 95% Confidence Intervals for GAD (Left) and Depression (Right) for Each Weight Category.

Missingness analysis

The test-set balanced accuracy scores for the XGBoost algorithm classification of participant response at each timepoint are shown in Table 3, which shows that the algorithm can predict participation with a higher than chance accuracy–the balanced accuracy scores range from 0.58 in the last timepoint, to 0.70 for month 8 (the balanced accuracy of random chance classification would be 0.50). Fig 3 shows the participants in each of the three weight categories (left hand side) and the relative impacts of each predictor (right hand side). The proportions are well balanced across the three weight categories, with no substantial qualitative differences apparent from this plot. For the predictors, depression was the most stably important predictor of participation across all timepoints, followed closely by anxiety. Age became substantially important as a predictor of response in timepoints 8 and 12 and was otherwise similar in its importance for predicting response to anxiety. Neither gender nor weight category were useful in predicting participant response, suggesting that these factors were well balanced across timepoints. The directions of these predictive effects can be observed in Fig 4. From these results we found that people higher in depression were consistently less likely to be classified as responding. This suggests that people high in depression either dropped-out or did not respond to invitations during top-up and/or subsequent recruitment periods.

Table 3. Balanced accuracy scores for the XGBoost classification.

Month Balanced Accuracy
0 0.66
1 0.61
4 0.62
8 0.70
12 0.69
17 0.67
20 0.59
24 0.58

Balanced accuracy scores for the classification of each participant’s participant at each of the 8 timepoints. Higher is better, and 0.5 represents chance level classification performance.

Fig 3. Response rates and SHAP predictor importances.

Fig 3

Fig 4. SHAP per-predictor, per-datapoint model impact results.

Fig 4

For the classification of whether each participant in the aggregate sample responded at each of the 8 timepoints, we provide the SHAP impacts (in units of log(odds)) for each datapoint for each predictor, for each participant. For example, in Month 0, we see that high levels of depression (red), have a negative impact on the impact on the model output, which is measured in log(odds). In other words, a participant with high levels of depression is likely to be classified as not responding at this timepoint.

Discussion

The results of the present study showed that individuals living with obesity struggled more with poor mental health (depression and anxiety) compared to people who were overweight or normal weight over two years during the pandemic. Individuals who were overweight also reported higher scores on depression and anxiety compared to normal weight individuals, but the difference was smaller. It is well-documented in the literature that people living with obesity are at greater risk of poorer mental health outcomes [e.g., 8] and we robustly illustrate that the pattern of comparison with those of lower weights is consistent over the long term. The scores on the mental health measures for those living with obesity reached levels that would be clinically indicative of mild-moderate anxiety [27] and moderate depressive disorder [18]. Within these data, we further illustrate the bi-directional relationship between obesity and poor mental health illustrated by Lavallee et al. and Moussa et al. [6, 7], whereby individuals in our sample who reported being heavier, showed worse mental health outcomes. This is one of the first studies of its kind to document in a large representative sample the association between obesity and mental health outcomes during the pandemic and the first to document the trajectories between weight categories over such a long time period.

The scale of the C-19 PRC study allowed us to investigate sample attrition, which is an important consideration for estimating population health from research. The results from the missingness analyses suggest that while there was no apparent bias in the weight categories (i.e., proportions in the weight categories remained fairly stable over time), people who were more depressed, and to a lesser extent more anxious, were less likely to participate in follow-up survey points. Therefore, the C-19 PRC survey, and others like it, are likely to actually underreport mental health problems over time due to differential drop-out. This has important implications for representing the realistic impact of (for example) obesity on mental health outcomes, as distress is likely to be underestimated.

There are clear implications from our findings for the direction of future research efforts in this field. We recommend a focus on providing combined interventions for people living with obesity that address both health and mental health issues to interrupt the enduring bi-directional cycle. Indeed, it is now generally acknowledged in the field that conceptualising obesity as a chronic, relapsing and multifaceted health condition is useful in addressing the myriad of bio-psycho-social influences that contribute to the development and maintenance of obesity and reducing stigma [28]. Mohseni et al. [29] reported improved health, behavioural and psychological outcomes (including anxiety, depression, stress and disordered eating) from a combined lifestyle/CBT intervention, which occurred independently of weight loss. A recent review also identified the positive impact of behavioural weight management interventions on depression and mental-health related quality of life in adults [30]. However, there appears to be a general lack of evidence for interventions that encompass the multifactorial nature of obesity, with treatment success often only measured by weight loss [29].

Since our analysis shows that longitudinal population surveys may be underreporting mental health problems over time, and the rates reported in our sample indicated clinical levels of distress, there is an even more pressing need to understand mental health outcomes for those living with obesity. Reporting and mitigating the occurrence of missing data in survey research is a general scientific issue [see, for example, 31]. However, to improve the methodological robustness of longitudinal surveys, it may be important to explore factors that might assist or motivate participation over time in those struggling with mental health issues to increase ecological validity and provide a more representative picture. Researchers conducting longitudinal survey studies might consider running a missingness analysis as a matter of course, to check whether a particular subsection of the sample is dropping out, and then employ strategies that enable continued representation from that group.

There are some limitations that need to be considered in interpreting our findings. First, the weight category of participants was not measured at all timepoints and thus we may have missed some participants as they dropped in and out of the study over time. Additionally, it was not possible to track changes in self-categorisation over time. There is some evidence that rates of obesity increased over the pandemic [see, for example 16, 32] but this survey was limited in the time points the measure was taken (Waves 3, 5, and 8). Finally, the weight category was self-reported instead of being calculated based on participants’ weight and height and therefore our categories could be inaccurate. Research shows that there are predictable inaccuracies in estimations of weight, such that those who are overweight tend to underestimate their weight status, as heavier weights become more ‘normalised’ [33]. Indeed, our data support findings that a substantial proportion of individuals with overweight or obesity may not identify accurately their weight status [34]. The average rates in each of the categories we report here indicate that significantly fewer people in our sample, compared to the general population, identified as being in the ‘obese’ category (8.6% in the sample, compared to 25.9% in the population) whereas, more people in our sample identified as being ‘overweight’ compared to population estimates (44.6% and 37.9% respectively). It is likely that, rather than individuals in our sample being on average of a lower weight than the general population, those of heavier weights have underestimated their weight and mis-categorised themselves, possibly because weight status is judged relative to visual body size norms (i.e., heavier body weights have become more normal and this has caused a recalibration of what is perceived as being ‘normal’ and ‘overweight’; [34]).

Conclusion

In conclusion, it is important that we remain vigilant to mental health problems experienced by people living with obesity and provide combined intervention where depression and anxiety are identified, as they are likely to be enduring. Further, since those with mental health problems are more likely to drop out of longitudinal survey studies, it is important to explore factors that might assist or motivate participation over time in under-reached groups and employ qualitative methodology to explore lived experience to gain a more in-depth picture of living with poor mental health and obesity.

Data Availability

The data underlying the results presented in the study are available from https://osf.io/v2zur/files/osfstorage.

Funding Statement

Gibson-Miller, J. Mental health and well being in people living with overweight and obesity during the COVID-19 pandemic. Research England COVID 19 Recovery Fund. Jan-July 2022. £29,148.

References

  • 1.Brown A., Flint S. W., Kalea A. Z., O’Kane M., Williams S., & Batterham R. L. (2021). Negative impact of the first COVID-19 lockdown upon health-related behaviours and psychological wellbeing in people living with severe and complex obesity in the UK. EClinicalMedicine, 34. doi: 10.1016/j.eclinm.2021.100796 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Melamed O. C., Selby P., & Taylor V. H. (2022). Mental Health and Obesity During the COVID-19 Pandemic. Current Obesity Reports, 1–9. 10.1007/s13679-021-00466-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Shevlin M., Butter S., McBride O., Murphy J., Gibson-Miller J., Hartman T. K., et al. (2023). Refuting the myth of a ‘tsunami’ of mental ill-health in populations affected by COVID-19: Evidence that response to the pandemic is heterogeneous, not homogeneous. Psychological Medicine, 53(2), 429–437. doi: 10.1017/S0033291721001665 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Catling J. C., Bayley A., Begum Z., Wardzinski C., & Wood A. (2022). Effects of the COVID-19 lockdown on mental health in a UK student sample. BMC Psychology, 10(1), 118. doi: 10.1186/s40359-022-00732-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Fiorillo A., & Gorwood P. (2020). The consequences of the COVID-19 pandemic on mental health and implications for clinical practice. European Psychiatry, 63(1). doi: 10.1192/j.eurpsy.2020.35 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lavallee K. L., Zhang X. C., Schneider S., & Margraf J. (2021). Obesity and Mental Health: A Longitudinal, Cross-Cultural Examination in Germany and China. Frontiers in Psychology, 12, 712567. doi: 10.3389/fpsyg.2021.712567 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Moussa O. M., Ardissino M., Kulatilake P., Faraj A., Muttoni E., Darzi A., et al. (2019). Effect of body mass index on depression in a UK cohort of 363 037 obese patients: A longitudinal analysis of transition. Clinical Obesity, 9(3), e12305. doi: 10.1111/cob.12305 [DOI] [PubMed] [Google Scholar]
  • 8.Musa AM, Cortese S, Bloodworth O. (2021) The association between obesity and depression in adults: a meta-review. BJPsych Open. 7(S1):S267–S267. doi: 10.1192/bjo.2021.712 [DOI] [Google Scholar]
  • 9.Abouzed M., Elsherbiny A.M., Kamel A., Salama B., Elag K.A., Abou Elzahab N.F., et al. (2022) Relation of Depression and Anxiety Disorders in Choosing Obesity Management in Obese Patients. Int J Prev Med. Oct 11;13:136. doi: 10.4103/ijpvm.ijpvm_102_21 ; PMCID: PMC9704478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Caretto A., Pintus S., Petroni M. L., Osella A. R., Bonfiglio C., Morabito S., et al. (2022). Determinants of weight, psychological status, food contemplation and lifestyle changes in patients with obesity during the COVID-19 lockdown: A nationwide survey using multiple correspondence analysis. International Journal of Obesity, 1–8. doi: 10.1038/s41366-022-01100-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Grannell A., le Roux C. W., & McGillicuddy D. (2020). ‘I am terrified of something happening to me’ The lived experience of people with obesity during the COVID-19 pandemic. Clinical Obesity, 10(6), e12406. doi: 10.1111/cob.12406 [DOI] [PubMed] [Google Scholar]
  • 12.Vallis M., & Glazer S. (2021). Protecting individuals living with overweight and obesity: Attitudes and concerns toward COVID‐19 vaccination in Canada. Obesity (Silver Spring, Md.), 29(7), 1128–1137. doi: 10.1002/oby.23182 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.McBride O., Butter S., Murphy J., Hartman T. K., McKay R., Hyland P., Shevlin M., et al. (2022). Tracking the psychological and socio-economic impact of the COVID-19 pandemic in the UK: A methodological report from Wave 5 of the COVID-19 Psychological Research Consortium (C19PRC) Study. International Journal of Methods in Psychiatric Research, e1928. 10.1002/mpr.1928 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.McBride O., Butter S., Murphy J., Shevlin M., Hartman T. K., Hyland P., et al. (2021). Context, design and conduct of the longitudinal COVID-19 psychological research consortium study–wave 3. International Journal of Methods in Psychiatric Research, 30(3), e1880. doi: 10.1002/mpr.1880 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.McBride O., Murphy J., Shevlin M., Gibson-Miller J., Hartman T. K., Hyland P., et al. (2021). Monitoring the psychological, social, and economic impact of the COVID-19 pandemic in the population: Context, design and conduct of the longitudinal COVID-19 psychological research consortium (C19PRC) study. International Journal of Methods in Psychiatric Research, 30(1), e1861. doi: 10.1002/mpr.1861 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Health Survey for England data (2021). Accessed on 5/3/2024 at: https://www.gov.uk/government/statistics/obesity-profile-update-may-2023/obesity-profile-short-statistical-commentary-may-2023 [Google Scholar]
  • 17.Kroenke K., Spitzer R. L., & Williams J. B. W. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613. doi: 10.1046/j.1525-1497.2001.016009606.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Manea L., Gilbody S., McMillan D. (2012) Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis. Can Med Assoc J. 184: E191–6. doi: 10.1503/cmaj.110829 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Spitzer R. L., Kroenke K., Williams J. B. W., & Löwe B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092–1097. doi: 10.1001/archinte.166.10.1092 [DOI] [PubMed] [Google Scholar]
  • 20.Berk M. (2018). Smoothing-splines Mixed-effects Models in R using the sme Package: A Tutorial. https://rdrr.io/cran/sme/f/inst/doc/Tutorial.pdf [Google Scholar]
  • 21.Friedman J. H. (2001). Greedy function approximation: A gradient boosting machine. The Annals of Statistics, 29(5), 1189–1232. 10.1214/aos/1013203451 [DOI] [Google Scholar]
  • 22.Chen T. & Guestrin C. (2016) XGBoost: A scalable tree boosting algorithm. KDD ‘16: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, pp.785.-. 10.1145/2939672.2939785 [DOI] [Google Scholar]
  • 23.Pedregosa F., Varoquaux G., Gramfort A., Michel V., Thirion B., Grisel O., et al. (2011) Journal of Machine Learning Research. 12(85), 2825–2839 http://jmlr.org/papers/v12/pedregosa11a.html [Google Scholar]
  • 24.Lundberg S. M., Allen P. G., & Lee S.-I. (2017). A unified approach to interpreting model predictions. Neural Information Processing Systems. https://github.com/slundberg/shap [Google Scholar]
  • 25.Lundberg S. M., Erion G., Chen H., DeGrave A., Prutkin J. M., Nair B., et al. (2020). From local explanations to global understanding with explainable AI for trees. Nature Machine Intelligence, 2(1), 56–67. doi: 10.1038/s42256-019-0138-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Shapley L. S. (1952). A Value for n-Person Games. RAND Corporation. 10.1515/9781400881970-018 [DOI] [Google Scholar]
  • 27.National Collaborating Centre for Mental Health (2018) Improving Access to Psychological Therapies Manual. [Google Scholar]
  • 28.Gibson-Miller J., Chater A. (2022) Ending weight-related stigma as the lynchpin for tackling obesity: a comment on the contribution of the UK’s policy response to obesity in the COVID-19 pandemic. Perspectives in Public Health. 142(1):15–17. doi: 10.1177/17579139211007885 [DOI] [PubMed] [Google Scholar]
  • 29.Mohseni M., Kuckuck S., Meeusen R.E.H., Jiskoot G., Lengton R., Savas M., et al. (2022) Improved Physical and Mental Health After a Combined Lifestyle Intervention with Cognitive Behavioural Therapy for Obesity. Int J Endocrinol Metab. Dec 29;21(1):e129906. doi: 10.5812/ijem-129906 ; PMCID: PMC10082324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Jones R.A., Lawlor E.R., Birch J.M., et al. (2021) The impact of adult behavioural weight management interventions on mental health: A systematic review and meta-analysis. Obesity Reviews. 22:e13150. doi: 10.1111/obr.13150 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Mirzaei A., Carter S.R., Patanwala A.E., Schneider C.R. (2022) Missing data in surveys: Key concepts, approaches, and applications, Research in Social and Administrative Pharmacy, Volume 18, Issue 2, Pages 2308–2316, 10.1016/j.sapharm.2021.03.009. [DOI] [PubMed] [Google Scholar]
  • 32.Nour T.Y., Altintaş K.H. (2023) Effect of the COVID-19 pandemic on obesity and its risk factors: a systematic review. BMC Public Health. 23(1):1018. doi: 10.1186/s12889-023-15833-2 ; PMCID: PMC10227822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Robinson E. (2017) Overweight but unseen: a review of the underestimation of weight status and a visual normalization theory. Obes Rev. Oct;18(10):1200–1209. doi: 10.1111/obr.12570 Epub 2017 Jul 21. ; PMCID: PMC5601193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Robinson E., Kersbergen I. (2017) Overweight or about right? A norm comparison explanation of perceived weight status. Obes. Sci. Pract. 3(1):36–43. doi: 10.1002/osp4.89 Epub 2017 Jan 25. ; PMCID: PMC5358078. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Jordi Gumà

16 Jan 2024

PONE-D-23-34311Longitudinal evidence over 2 years of the pandemic shows that poor mental health in people living with obesity may be underestimatedPLOS ONE

Dear Dr. Gibson-Miller,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

I particularly agree with the comments about the need to contextualize the theory underpinning the research question a little better. And above all, the need to expand the information on the C19PRC study. This I am convinced that will reinforce the strength of your contribution.

Please submit your revised manuscript by Mar 01 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Jordi Gumà, Ph.D.

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse.

3. Note from Emily Chenette, Editor in Chief of PLOS ONE, and Iain Hrynaszkiewicz, Director of Open Research Solutions at PLOS: Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data).

4. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

5. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I read this manuscript with manuscript ID: PONE-D-23-34311 for PLoS One with interest. The title is revealing and making a very strong claim (“Longitudinal evidence over 2 years of the pandemic shows that poor mental health in people living with obesity may be underestimated”). My main issue is that this manuscript was clearly intended as a “brief report” and not as a regular “research article”. As such, many important details are missing or banished to the supplementary materials (which I had no access to for some reason). My recommendation would be to expand the manuscript, specifically:

1. Expand the introduction with a literature review to strengthen your claim that the mental health burden is underestimated in the target population. If possible, estimates of the depressive and anxiety symptoms in the population of people with obesity should be stated explicitly (perhaps a range of estimates if no meta-analysis is available).

2. Please move Table 1 describing your sample from the supplements to the main body of the manuscript.

3. Please describe the C19PRC study. The references are great for further reading but some details of the sample are also necessary in the manuscript so your readers understand the sampling process, generalisability and validity of your results.

4. Please provide all information necessary to replicate your model. (Feel free to ignore this comment if your R code included with the supplementary materials.)

5. Could you please add drop-out rates per time point and to what extent did the study suffer from intermittent missingness?

6. Please discuss how your results fit in with or are different from other studies in the literature and also discuss how the chosen analyses may have impacted your findings.

Other comments (in no particular order):

7. It is unclear to me if the C19PRC study used a probabilistic sampling method and was representative of the population the sample was drawn from or not. Please state this explicitly in the methods. If the sample is non-probabilistic, then you should consider selection bias and how it could have affected the results.

8. Which countries participated in the study? How many participants were included from each country? Was the sample size (which could be stated in the main body of the text) considered in the analyses?

9. Do you have any means to verify the self-reported weight categories?

10. Do you have participants with lower-than-normal BMI? How many? How does merging this group with the “normal” BMI group affect your results?

11. Did you use the PHQ-9 and GAD-7 total scores as outcome for the mixed models? If so, were the residuals normally distributed?

12. Line 78: PHQ-9 measures depressive symptoms and not depression. I would recommend making this distinction clear in the manuscript.

13. Line 84: PHQ-9 and GAD-7 are both very skewed in the general population due to a flooring effect. Means and standard deviations are not very useful to describe the centre and spread of the distribution. I would recommend adding median, IQR and range.

14. To obtain the PHQ-9 and GAD-7 total scores, did you use only observations with all items, or did you use an imputation method if there was item-level incompleteness?

Finally, I would like to add that despite the numerous comments, I believe this paper could be an important contribution to the literature. I especially like the analysis of the missing values.

Reviewer #2: This manuscript describes the longitudinal trajectories of depression and anxiety during the COVID pandemic and their association with the weight status, by reporting 8-wave UK national data. The authors should be commended for their focus on the link between obesity and mental health during the pandemic. However, despite the good methodology and data analysis, the study has a few shortcomings that need to be addressed on which I elaborate below.

It is unclear how the current study addressed the causal link between obesity and mental health. In my view, the current results only show that individuals with obesity reported higher levels of depression and anxiety than overweight or normal weight people. A cross-lagged panel analysis could be more suitable if the goal of the study is to examine whether the obesity status predicts depression and anxiety or vice versa. Please report the aim of this study with greater clarity.

Related to the above, what is the rationale for investigating drop-out and top-up participation effect? We have no information on that in the Introduction, and a clear aim for this point is lacking.

The description of the characteristics of the sample is poorly reported. Although the procedure of the study is reported in previous papers, it is important to describe how participants were selected and recruited online. Is it a nationally representative sample?

Moreover, we have no information on demographics such as nationality (or minoritized identity groups), income, health condition, access to care, as well as data on COVID-related restrictions (i.e. lockdown), number of infections/deaths. Given that these data varied across countries and regions during the pandemic, it is important to see if some of these variables had an impact on psychological distress.

It is also important to know how many individuals reported an obesity condition before the pandemic, given the meta-analytic evidence of an increase of weight problems among the general population during the COVID outbreak.

Moreover, we know that psychological distress among the obese population can be linked to binge eating behaviors. Do the authors have data on eating symptoms or dysfunctional eating behaviors for this sample during the pandemic?

My main concern is that participants were asked to self-identify into weight categories, but we have no validity checks on these responses. For example, did participants rate their weight according to clear criteria? How can an individual distinguish between the categories of being overweight and being obese? Participants did not report their weight and height, and the weight status seems unclear.

The results section is well-reported.

The discussion section can be enriched in a number of ways. For example, what the current findings add to the literature on obesity and mental health during the pandemic? There are a number of studies and meta-analyses on this topic that could be used to improve this section.

It may be worthwhile to expand on how the current data on mental health trajectories add to the literature on mental health distress during the pandemic. This research topic has been addressed extensively over the last 2 years and should be discussed in more detail.

Reviewer #3: In the manuscript PONE-D-23-34311 the Authors examined the trajectories of depression and anxiety in people with obesity over two years across eight waves of a UK national COVID-19 survey (March 2020-March 2022). Trajectory models showed that those overweight and with obesity consistently reported significantly higher rates of anxiety and depression compared to those in normal weight categories over two years. The analysis revealed that depression and anxiety predicted the likelihood of responding to the survey over time, whereas those reporting higher rates of depression and anxiety were less likely to respond to the survey.

I believe that the study undertaken by the authors is valuable, relevant and topical to the subject of public health. Their findings may not only deepen the existing knowledge of the potential mental health problems of people living with obesity, but also contribute to the search for practical solutions to improve their quality of life. My general impression of the manuscript was positive. I recommend the manuscript for publication with a few modifications:

• I suggest structuring the Methods section with subheadings for easier navigation and greater clarity.

• Please complete the Methods section with information on the characteristics of the study group.

• Please include information on Ethical Approval.

• The discussion seems too general and needs refinement. First of all, I suggest creating connections to previous research and ongoing discourse.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Jul 25;19(7):e0305627. doi: 10.1371/journal.pone.0305627.r002

Author response to Decision Letter 0


12 Mar 2024

Reviewer #1: I read this manuscript with manuscript ID: PONE-D-23-34311 for PLoS One with interest. The title is revealing and making a very strong claim (“Longitudinal evidence over 2 years of the pandemic shows that poor mental health in people living with obesity may be underestimated”). My main issue is that this manuscript was clearly intended as a “brief report” and not as a regular “research article”. As such, many important details are missing or banished to the supplementary materials (which I had no access to for some reason). My recommendation would be to expand the manuscript, specifically:

1. Expand the introduction with a literature review to strengthen your claim that the mental health burden is underestimated in the target population. If possible, estimates of the depressive and anxiety symptoms in the population of people with obesity should be stated explicitly (perhaps a range of estimates if no meta-analysis is available).

We have expanded the introduction and refined our research questions to make our claims clear. We believe that the findings of our study indicate that the mental health burden in this population may well be underestimated using longitudinal survey methodology. Whilst findings in the current literature indicate clearly that this burden is significant, and our work supports that, few studies have investigated attrition in this way. Our revised introduction explains this more clearly.

2. Please move Table 1 describing your sample from the supplements to the main body of the manuscript.

Thanks, this Table has now been moved to the main manuscript.

3. Please describe the C19PRC study. The references are great for further reading but some details of the sample are also necessary in the manuscript so your readers understand the sampling process, generalisability and validity of your results.

We have now added a paragraph in the Methods section that describes the C19PRC study in more detail.

4. Please provide all information necessary to replicate your model. (Feel free to ignore this comment if your R code included with the supplementary materials.)

We have included the R and Python scripts in supplementary material.

5. Could you please add drop-out rates per time point and to what extent did the study suffer from intermittent missingness?

As the dynamics of participation can be difficult to summarize succinctly, we have provided this information in the manuscript (see Fig 1 and Table 2, below). As can be seen, the dropout/participation dynamics are complex. We hope that an evaluation of such dynamics can be encouraged in future work in the area.

Figure 1

Participant participation (black) or absence (white) sorted by degree of participation over time (high participation at the top, low participation at the bottom).

Table 2

How many participants completed at least X number of timepoints (two leftmost columns), and how many participants there were at each timepoint (two rightmost columns).

No. of Timepoints No. with at least X Timepoints of Participation Month No. of Participants

(% of total participants)

1 4143 0 1479 (36.7%)

2 3097 1 1168 (28.2%)

3 2150 4 1944 (46.9%)

4 1756 8 2574 (62.1%)

5 1452 12 2445 (59.0%)

6 1082 17 1600 (38.6%)

7 657 20 1292 (31.2%)

8 317 24 2072 (50.0%)

6. Please discuss how your results fit in with or are different from other studies in the literature and also discuss how the chosen analyses may have impacted your findings.

We have now expanded the discussion section to include more context to our findings.

Other comments (in no particular order):

7. It is unclear to me if the C19PRC study used a probabilistic sampling method and was representative of the population the sample was drawn from or not. Please state this explicitly in the methods. If the sample is non-probabilistic, then you should consider selection bias and how it could have affected the results.

The information we have added to the Methods section covers this point. We state that: “Quota sampling was used to recruit a panel of adults who were nationally representative of the UK population in terms of age, sex, and household income.”

Of course it is possible that a different sampling method may impact the results, because it may change the substrata of participants who do or do not respond at particular time points. However, to say exactly in which direction the results would change is difficult and would only be speculative, therefore we have not expanded on this in the manuscript.

8. Which countries participated in the study? How many participants were included from each country? Was the sample size (which could be stated in the main body of the text) considered in the analyses?

The data we analysed here was from the UK arm of the study, so includes participants from England, Scotland, Wales, and Northern Ireland. For the analyses, the full sample size for anyone who completed at least one time point was used (N=4143). The multilevel spline method takes advantage of data wherever it is available. For the missingness analysis, for each participant, a label for participant was assigned for each timepoint, thus even if a participant only participated once, we could still make predictions using the information collected at that time point to predict their participation at other timepoints.

The following sample size information has been added to the manuscript in the data analysis section:

“To make the predictions, we aggregated all people who participated at least once in the longitudinal study (N=4143).”

See also Table 2, which provides more information on the dropout/participation rates at each timepoint.

9. Do you have any means to verify the self-reported weight categories?

We have utilised self-reported data on weight category as we were unable to take verifiable measures of BMI due to the design of the study. Research shows that there are inaccuracies in self-perception of weight, such that it is likely that our sample have underestimated their body size. We discuss this literature and acknowledge this as a limitation of the study in the revised discussion section.

10. Do you have participants with lower-than-normal BMI? How many? How does merging this group with the “normal” BMI group affect your results?

There are 160 people in the sample who identified as being underweight, but these participants were not included as part of the original analyses. If we combine the underweight with the normal weight, the results barely change. For example, here are the balanced accuracies for when the two lowest weight classes are combined:

Month Balanced_Acc

0 0.65

1 0.60

4 0.64

8 0.70

12 0.71

17 0.70

20 0.61

24 0.58

Compared with the original:

Month Balanced Accuracy

0 0.66

1 0.61

4 0.62

8 0.70

12 0.69

17 0.67

20 0.59

24 0.58

Similarly, the results for the important predictors in the combined sample:

are very similar to the original;

11. Did you use the PHQ-9 and GAD-7 total scores as outcome for the mixed models? If so, were the residuals normally distributed?

Yes, the summary scores were used for the mixed models. The residuals are not normally distributed - see example diagnostic plot for the depression outcome of the normal weight group:

In our experience, this is quite common with such models, particularly when paired with real-world data which, as the reviewer highlights below, are often skewed by floor or ceiling effects.

However, our goal is not to derive and interpret parameter estimates for these models (doing so is already non-trivial given the non-linear nature of the models), but to fit a smooth trajectory to the depression and GAD scores over time. This is done to broadly characterise the differences between the groups, and we also provide the raw mean scores for comparison in the supplementary material. As such, given that we are not interpreting the coefficients of these models (e.g. with respect to significance) our view is that the non-normality of the errors does not impact the principal take-away regarding the average differences in perceived weight class between groups, over time.

12. Line 78: PHQ-9 measures depressive symptoms and not depression. I would recommend making this distinction clear in the manuscript.

Thanks, we have changed this accordingly throughout the manuscript.

13. Line 84: PHQ-9 and GAD-7 are both very skewed in the general population due to a flooring effect. Means and standard deviations are not very useful to describe the centre and spread of the distribution. I would recommend adding median, IQR and range.

Thanks for the suggestion, we have added two tables to the Supplementary material including the median, IQR, and range for each month, for each weight category, for depression and anxiety separately (Table S3 and S4, respectively).

14. To obtain the PHQ-9 and GAD-7 total scores, did you use only observations with all items, or did you use an imputation method if there was item-level incompleteness?

As this was a secondary data analysis, we used the publicly available data set, which included completed computation methods for missing data.

Finally, I would like to add that despite the numerous comments, I believe this paper could be an important contribution to the literature. I especially like the analysis of the missing values.

Many thanks for your positive feedback!

Reviewer #2: This manuscript describes the longitudinal trajectories of depression and anxiety during the COVID pandemic and their association with the weight status, by reporting 8-wave UK national data. The authors should be commended for their focus on the link between obesity and mental health during the pandemic. However, despite the good methodology and data analysis, the study has a few shortcomings that need to be addressed on which I elaborate below.

1. It is unclear how the current study addressed the causal link between obesity and mental health. In my view, the current results only show that individuals with obesity reported higher levels of depression and anxiety than overweight or normal weight people. A cross-lagged panel analysis could be more suitable if the goal of the study is to examine whether the obesity status predicts depression and anxiety or vice versa. Please report the aim of this study with greater clarity.

We agree with the reviewer and have removed the comment about causality from the introduction. We believe the aims of the study are now clearer in the revised introduction.

2. Related to the above, what is the rationale for investigating drop-out and top-up participation effect? We have no information on that in the Introduction, and a clear aim for this point is lacking.

Indeed, we have revised the introduction to cover this point in more detail.

3.The description of the characteristics of the sample is poorly reported. Although the procedure of the study is reported in previous papers, it is important to describe how participants were selected and recruited online. Is it a nationally representative sample?

Please also see response to reviewer 1, point 3. We have now included more information about the C-19 PRC study in the methodology section of the paper. Yes, the sample was selected to be representative of the UK population. We have also provided a Table in the manuscript (Table 1) describing the sample.

4. Moreover, we have no information on demographics such as nationality (or minoritized identity groups), income, health condition, access to care, as well as data on COVID-related restrictions (i.e. lockdown), number of infections/deaths. Given that these data varied across countries and regions during the pandemic, it is important to see if some of these variables had an impact on psychological distress.

First, to be clear, our study reports on UK data only and therefore no comparisons across countries are presented. As we took our sample across 8 waves of data and the sample would have varied over time, we felt that presenting this demographic data would be unnecessarily complex and not add to the study presented here. However, we have added summary data for anxiety and depression scores to Table 1 (please also see response to Reviewer 1, point 2).

5. It is also important to know how many individuals reported an obesity condition before the pandemic, given the meta-analytic evidence of an increase of weight problems among the general population during the COVID outbreak.

We have added population level estimates of overweight and obesity pre-and post-pandemic in our revised introduction and discussion sections. We discuss the rates of overweight and obesity in relation to our sample and acknowledge the limitations in the timing of our measurements.

6. Moreover, we know that psychological distress among the obese population can be linked to binge eating behaviors. Do the authors have data on eating symptoms or dysfunctional eating behaviors for this sample during the pandemic?

Unfortunately, we do not have data on eating behaviour from the C-19 PRC study.

7. My main concern is that participants were asked to self-identify into weight categories, but we have no validity checks on these responses. For example, did participants rate their weight according to clear criteria? How can an individual distinguish between the categories of being overweight and being obese? Participants did not report their weight and height, and the weight status seems unclear.

Please also see response to reviewer 1, point 9. The reviewer is correct, that we were unable to verify the weight categories chosen by participants due to the design of the study. The categorisation relied solely on self-perception. Research shows that there are inaccuracies in self-perception of weight, such that it is likely that our sample have underestimated their body size. We discuss this literature and acknowledge this as a limitation of the study in the revised discussion section.

8. The results section is well-reported.

Thank you.

9. The discussion section can be enriched in a number of ways. For example, what the current findings add to the literature on obesity and mental health during the pandemic? There are a number of studies and meta-analyses on this topic that could be used to improve this section.

10. It may be worthwhile to expand on how the current data on mental health trajectories add to the literature on mental health distress during the pandemic. This research topic has been addressed extensively over the last 2 years and should be discussed in more detail.

The discussion section has now been expanded to incorporate these and the other reviewers' suggestions.

Reviewer #3: In the manuscript PONE-D-23-34311 the Authors examined the trajectories of depression and anxiety in people with obesity over two years across eight waves of a UK national COVID-19 survey (March 2020-March 2022). Trajectory models showed that those overweight and with obesity consistently reported significantly higher rates of anxiety and depression compared to those in normal weight categories over two years. The analysis revealed that depression and anxiety predicted the likelihood of responding to the survey over time, whereas those reporting higher rates of depression and anxiety were less likely to respond to the survey.

I believe that the study undertaken by the authors is valuable, relevant and topical to the subject of public health. Their findings may not only deepen the existing knowledge of the potential mental health problems of people living with obesity, but also contribute to the search for practical solutions to improve their quality of life. My general impression of the manuscript was positive. I recommend the manuscript for publication with a few modifications:

We thank the reviewer for their positive assessment of the paper and suggestions for revision.

1. I suggest structuring the Methods section with subheadings for easier navigation and greater clarity.

Thanks, we have changed this accordingly.

2. Please complete the Methods section with information on the characteristics of the study group.

Please see response to reviewer 2, point 4.

3. Please include information on Ethical Approva

Attachment

Submitted filename: Response to reviewers.docx

pone.0305627.s001.docx (706.5KB, docx)

Decision Letter 1

Jordi Gumà

4 Jun 2024

Longitudinal evidence over 2 years of the pandemic shows that poor mental health in people living with obesity may be underestimated

PONE-D-23-34311R1

Dear Dr. Gibson-Miller,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Jordi Gumà, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #3: I would like to thank the Authors for considering and responding to my comments. I have reviewed their responses and the revised manuscript, and I have no further concerns to raise. I think this is a good study with good statistical support. This current version of the manuscript meets the criteria of the PLOS ONE, and I would support its publication based on this revision.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: No

**********

Acceptance letter

Jordi Gumà

18 Jun 2024

PONE-D-23-34311R1

PLOS ONE

Dear Dr. Gibson-Miller,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Jordi Gumà

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to reviewers.docx

    pone.0305627.s001.docx (706.5KB, docx)

    Data Availability Statement

    The data underlying the results presented in the study are available from https://osf.io/v2zur/files/osfstorage.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES